Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan

por Cheng, Shu-Hsing, Cheng, Chien-Yu, Sun, Na-Lee
Publicado 2014

Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222

por Cheng, Shu-Hsing, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Chien-Yu
Publicado 2022

Multiple types of human papillomavirus infection and anal precancerous lesions in HIV-infected men in Taiwan: a cross-sectional study

por Cheng, Shu-Hsing, Liao, Kuo-Sheng, Wang, Chi-Chao, Cheng, Chien-Yu, Chu, Fang-Yeh
Publicado 2018

A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response

por Lin, Yi-Chun, Cheng, Chien-Yu, Chen, Cheng-Pin, Cheng, Shu-Hsing, Chang, Sui-Yuan, Hsueh, Po-Ren
Publicado 2020

Predicting Emotional Valence of People Living with the Human Immunodeficiency Virus Using Daily Voice Clips: A Preliminary Study

por Lin, Ray F., Cheng, Shu-Hsing, Liu, Yung-Ping, Chen, Cheng-Pin, Wang, Yi-Jyun, Chang, Shu-Ying
Publicado 2021

Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV

por Cheng, Chien-Yu, Ku, Shin-Yen, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Shu-Hsing, Lin, I-Feng
Publicado 2022

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study

por Yang, Chin-Hui, Chen, Kuan-Jung, Tsai, Jih-Jin, Lin, Yu-Hui, Cheng, Shu-Hsing, Wang, Kwei-Feng, Chiou, Hung-Yi
Publicado 2014

Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection

por Wu, Pei-Ying, Cheng, Chien-Yu, Luo, Yu-Zhen, Zhang, Jun-Yu, Yang, Shan-Ping, Cheng, Shu-Hsing, Hung, Chien-Ching
Publicado 2014

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

por Cheng, Chien-Yu, Lee, Yu-Lin, Chen, Cheng-Pin, Lin, Yi-Chun, Liu, Chun-Eng, Liao, Chia-Hung, Cheng, Shu-Hsing
Publicado 2020

Clinical validation of an automated reverse transcription-insulated isothermal PCR assay for the detection of severe acute respiratory syndrome coronavirus 2

por Chang, Pai-Ling, Lin, Chia-Yi, Chen, Cheng-Pin, Lin, Yi-Chun, Hu, Hui-Chun, Cheng, Shu-Hsing, Cheng, Chien-Yu
Publicado 2021

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population

por Yang, Chin-Hui, Chan, Pei-Chun, Liao, Say-Tsung, Cheng, Shu-Hsing, Wong, Wing-Wai, Huang, Li-Min, Hsueh, Po-Ren, Chiou, Hung-Yi
Publicado 2013

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)

por Cheng, Chien-Yu, Luo, Yu-Zhen, Wu, Pei-Ying, Liu, Wen-Chun, Yang, Shan-Ping, Zhang, Jun-Yu, Cheng, Shu-Hsing, Hung, Chien-Ching
Publicado 2014

Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants

por Chen, Cheng-Pin, Huang, Kuan-Ying A., Shih, Shin-Ru, Lin, Yi-Chun, Cheng, Chien-Yu, Huang, Yhu-Chering, Lin, Tzou-Yien, Cheng, Shu-Hsing
Publicado 2022

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901

por Estrada, Josue Antonio, Cheng, Chien-Yu, Ku, Shin-Yen, Hu, Hui-Chun, Yeh, Hsiu-Wen, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Shu-Hsing, Janssen, Robert, Lin, I-Feng
Publicado 2022

Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter...

por Cheng, Chien-Yu, Tsai, Mao-Song, Yang, Chia-Jui, Cheng, Shu-Hsing, Sun, Hsin-Yun, Chang, Shu-Fang, Su, Li-Hsin, Su, Yi-Ching, Hung, Chien-Ching, Chang, Sui-Yuan
Publicado 2018

Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

por Lin, Yi-Chun, Li, Shih-Wei, Ku, Shin-Yen, Hsieh, Hui-Ting, Lin, Mei-Hui, Chang, Shu-Yin, Wu, Wei-Wei, Sun, Na-Lee, Cheng, Shu-Hsing, Cheng, Chien-Yu
Publicado 2019

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination

por Sheng, Wang-Huei, Chang, Sui-Yuan, Lin, Pin-Hung, Hsieh, Ming-Ju, Chang, Hao-Hsiang, Cheng, Chien-Yu, Yang, Hung-Chih, Pan, Ching-Fu, Ieong, Si-Man, Chao, Tai-Ling, Chen, Jang-Pin, Cheng, Shu-Hsing, Chang, Shan-Chwen
Publicado 2022

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-t...

por Wu, Pei-Ying, Cheng, Chien-Yu, Liu, Chun-Eng, Lee, Yi-Chien, Yang, Chia-Jui, Tsai, Mao-Song, Cheng, Shu-Hsing, Lin, Shih-Ping, Lin, De-Yu, Wang, Ning-Chi, Lee, Yi-Chieh, Sun, Hsin-Yun, Tang, Hung-Jen, Hung, Chien-Ching
Publicado 2017

Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation

por Chao, Tai-Ling, Lee, Wen-Hau, Hu, Hui-Chun, Lin, Yi-Chun, Ho, Shu-Yuan, Chen, Hui-Hou, Chen, Cheng-Pin, Tsai, Ya-Min, Fang, Jun-Tung, Leong, Si-Man, Cheng, Yu-Chen, Peng, Mavis, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chang, Sui-Yuan
Publicado 2023

Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide amon...

por Huang, Yu-Shan, Cheng, Chien-Yu, Sun, Hsin-Yun, Cheng, Shu-Hsing, Lu, Po-Liang, Lee, Chen-Hsiang, Lee, Yuan-Ti, Tsai, Hung-Chin, Yang, Chia-Jui, Liu, Chun-Eng, Liou, Bo-Huang, Lin, Shih-Ping, Huang, Sung-Hsi, Ho, Mao-Wang, Tang, Hung-Jen, Hung, Chien-Ching
Publicado 2023